{"group":{"slug":"opioid-class-action","title":"Opioid Class Action","summary":"Three proposed settlements with Purdue Canada, Valeant and Mylan in the national opioid class action, Gebien v. Apotex, brought on behalf of Canadians who were prescribed or consumed opioid products and allege opioid dependency or addiction. Each settling defendant denies the allegations and the class action continues against the remaining defendants.","membersIntro":null,"structure":"multi_settlement","members":[{"slug":"purdue-canada-opioids-2026","title":"Purdue Canada Settlement","classDefinition":"All persons in Canada, except Excluded Persons, who were prescribed or consumed any opioid Product, together with their heirs, and any member of the Family Law Class (relatives with standing under s. 61(1) of the Family Law Act or equivalent legislation). Excluded Persons include anyone prescribed only OxyContin or OxyNEO between January 1, 1996 and February 28, 2017 and no other Products, officers or directors of the defendants, and members of the class in the Bourassa Class Action.","status":"Claims not yet open","geographic":["Canada-wide"],"deadline":"","lastVerifiedAt":"2026-08-16","isSelf":false},{"slug":"valeant-opioid-settlement-2026","title":"Valeant and Bausch Health Settlement","classDefinition":"All persons in Canada (except Quebec) who were prescribed or consumed any opioid product (as defined in the Settlement Agreement), together with their heirs, and any member of the Family Law Class. The Family Law Class includes persons who, by reason of a relationship to a Class Member, have standing under section 61(1) of the Family Law Act or equivalent legislation.","status":"Claims not yet open","geographic":["Canada-wide (Except Quebec)"],"deadline":"","lastVerifiedAt":"2026-08-16","isSelf":false},{"slug":"national-opioids-mylan-2026","title":"Mylan Settlement","classDefinition":"All persons in Canada (except Quebec) who were prescribed or consumed any opioid Product, together with their heirs, and any member of the Family Law Class. The Family Law Class includes all persons in Canada who, by reason of a relationship to a Class Member, have standing under section 61(1) of Ontario's Family Law Act or equivalent legislation in another province or territory, or the common law.","status":"Claims not yet open","geographic":["Canada-wide (Except Quebec)"],"deadline":"","lastVerifiedAt":"2026-08-16","isSelf":false}]},"settlements":[{"id":"purdue-canada-opioids-2026","slug":"purdue-canada-opioids-2026","title":"Purdue Canada Settlement","category":"Pharmaceutical and Medical Devices","status":"Claims not yet open","tags":{"industry":["Pharmaceutical and medical devices"],"geographic":["Canada-wide"],"recoveryType":["Cash payment"],"documentation":["To be determined"],"eligibilityTrigger":["Was a patient or received treatment"]},"classDefinition":"All persons in Canada, except Excluded Persons, who were prescribed or consumed any opioid Product, together with their heirs, and any member of the Family Law Class (relatives with standing under s. 61(1) of the Family Law Act or equivalent legislation). Excluded Persons include anyone prescribed only OxyContin or OxyNEO between January 1, 1996 and February 28, 2017 and no other Products, officers or directors of the defendants, and members of the class in the Bourassa Class Action.","plainLanguageSummary":"If you were prescribed or consumed opioid products in Canada, or you are a close relative of someone who was, you may be eligible for a share of a proposed CAD $28,500,000 settlement with Purdue Canada once it is approved by the Court.","eligibilityCriteria":[],"recoveryRange":"Share of a CAD $28,500,000 settlement fund, individual amounts to be determined","filingInstructions":"","caseBackground":"A national class action claims that several pharmaceutical companies promoted opioid medications for chronic conditions starting in the 1990s without properly warning about the risk of addiction. The lawsuit says this led to widespread opioid dependency and addiction among people who were prescribed these medications.\n\nThe plaintiffs have reached a proposed settlement with Purdue Pharma Inc. and Purdue Frederick Inc. (together, Purdue Canada) for a payment of CAD $28,500,000. Purdue Canada denies the allegations and no court has found it liable. The settlement must still be approved by the Ontario Superior Court of Justice at a hearing on September 16, 2026, and the lawsuit continues against the other pharmaceutical companies. A plan for distributing the money to class members is expected later in 2026.","administratorName":"","administratorContacts":[],"administratorRole":"claims","agentName":null,"agentContacts":[],"agentClaimFormHelp":false,"classCounselName":"Koskie Minsky LLP","classCounselContacts":[{"type":"phone","label":"","value":"1-833-630-1776"},{"type":"email","label":"","value":"opioidclassaction@kmlaw.ca"},{"type":"mail","label":"","value":"Koskie Minsky LLP, 20 Queen Street West, Suite 900, Toronto, ON, M5H 3R3"},{"type":"online","label":"","value":"https://kmlaw.ca/cases/liability-for-opioid-epidemic/"}],"classCounselFirms":[{"name":"Koskie Minsky LLP","region":"","contacts":[{"type":"phone","label":"","value":"1-833-630-1776"},{"type":"email","label":"","value":"opioidclassaction@kmlaw.ca"},{"type":"mail","label":"","value":"Koskie Minsky LLP, 20 Queen Street West, Suite 900, Toronto, ON, M5H 3R3"},{"type":"online","label":"","value":"https://kmlaw.ca/cases/liability-for-opioid-epidemic/"}]}],"submissionMethods":[],"sourceDocuments":[{"url":"/uploads/e92de0683ad72371bf7a41d9-Long_Form_Notice_of_Certification_and_Settlement_Approval_Hearing_Purdue_Mar_26.pdf","title":"Notice to Class Members"},{"url":"/uploads/ec7d52096cd61b23395e122f-ng-Form-Notice_of_Certification_and_Settlement_Approval_Hearing_Purdue_FR_Mar_26.pdf","title":"Avis aux membres du groupe"}],"shortFormNoticeUrl":"/uploads/98829dd0b04485f56d203d6e-Short_Form_Notice_of_Certification_and_Settlement_Approval_Hearing_Purdue_Mar_26.pdf","longFormNoticeUrl":"/uploads/e92de0683ad72371bf7a41d9-Long_Form_Notice_of_Certification_and_Settlement_Approval_Hearing_Purdue_Mar_26.pdf","settlementAgreementUrl":"","claimFormDocumentUrl":"","claimForms":[],"claimFormsButtonLabel":"claim-form","claimFormsUnavailable":false,"claimFormsUnavailableReason":null,"claimFormGuides":[],"additionalDocuments":[],"optOutFormUrl":"","optOutInstructions":"To opt out, you must send a completed Opt Out Request to Class Counsel on or before May 4, 2026, by email to opioidclassaction@kmlaw.ca or by mail to Re: Opioids Class Action, Koskie Minsky LLP, 20 Queen Street West, Suite 900, Toronto, ON, M5H 3R3. The Opt Out Request form is available from Class Counsel. The opt-out deadline of May 4, 2026 has now passed.","objectionFormUrl":null,"objectionInstructions":null,"faqs":[{"answer":"Purdue Canada has agreed to pay CAD $28,500,000 to settle the claims against it. Individual payment amounts have not been determined yet; a distribution plan is expected to be proposed to the Court later in 2026.","question":"How much money is in the settlement?"},{"answer":"Not yet. The settlement must first be approved by the Court at a hearing on September 16, 2026. If it is approved, further information will be provided about how to make a claim for compensation. You can register at opioidclassaction@kmlaw.ca to receive future notices.","question":"When can I make a claim?"},{"answer":"No. The deadline to submit an Objection Form or an Opt Out Request to Class Counsel was May 4, 2026, and it has passed.","question":"Can I still object to the settlement or opt out?"},{"answer":"If you do nothing, you remain in the class. If the Court approves the settlement, you will be eligible to make a claim for compensation but will not be able to sue Purdue Canada individually about the claims the settlement resolves.","question":"What happens if I do nothing?"},{"answer":"No. Class members are not charged for Class Counsel's services. Class Counsel will ask the Court to approve a fee of 25% of the settlement funds, and a court-approved litigation funder will receive a return of 11% of the settlement funds and related costs.","question":"Do I have to pay the lawyers?"}],"eligibilityChecker":{"questions":[{"id":"prescribed-or-consumed-opioids","text":"Were you prescribed or did you consume any opioid product in Canada, or are you the heir of someone who was, or a family member with a claim through them?","type":"yes_no","helpText":"Family members may qualify under family law legislation because of their relationship to a person who took opioids.","qualifyingAnswer":"yes","criticalForEligibility":true},{"id":"only-oxycontin-oxyneo","text":"Were you prescribed only OxyContin or OxyNEO in Canada between January 1, 1996 and February 28, 2017, and no other opioid products during the class period?","type":"yes_no","helpText":"People whose only prescriptions were OxyContin or OxyNEO in that period are excluded because they are covered by a different class action.","qualifyingAnswer":"no","criticalForEligibility":true},{"id":"officer-or-director","text":"Are you an officer or director of any of the defendant pharmaceutical companies?","type":"yes_no","qualifyingAnswer":"no","criticalForEligibility":true},{"id":"bourassa-class-member","text":"Are you a member of the class in the Bourassa Class Action?","type":"yes_no","qualifyingAnswer":"no","criticalForEligibility":true}],"uncertainMessage":"Some of your answers were Not sure, so we could not confidently determine your eligibility.","qualifyingMessage":"Based on your answers, you appear to fall within the class definition for this settlement.","nonQualifyingMessage":"Based on your answers, you do not appear to fall within the class definition for this settlement."},"claimCategories":[],"proceedings":null,"relatedSlugs":[],"group":{"slug":"opioid-class-action","title":"Opioid Class Action","summary":"Three proposed settlements with Purdue Canada, Valeant and Mylan in the national opioid class action, Gebien v. Apotex, brought on behalf of Canadians who were prescribed or consumed opioid products and allege opioid dependency or addiction. Each settling defendant denies the allegations and the class action continues against the remaining defendants.","membersIntro":null,"structure":"multi_settlement","members":[{"slug":"purdue-canada-opioids-2026","title":"Purdue Canada Settlement","classDefinition":"All persons in Canada, except Excluded Persons, who were prescribed or consumed any opioid Product, together with their heirs, and any member of the Family Law Class (relatives with standing under s. 61(1) of the Family Law Act or equivalent legislation). Excluded Persons include anyone prescribed only OxyContin or OxyNEO between January 1, 1996 and February 28, 2017 and no other Products, officers or directors of the defendants, and members of the class in the Bourassa Class Action.","status":"Claims not yet open","geographic":["Canada-wide"],"deadline":"","lastVerifiedAt":"2026-08-16","isSelf":true},{"slug":"valeant-opioid-settlement-2026","title":"Valeant and Bausch Health Settlement","classDefinition":"All persons in Canada (except Quebec) who were prescribed or consumed any opioid product (as defined in the Settlement Agreement), together with their heirs, and any member of the Family Law Class. The Family Law Class includes persons who, by reason of a relationship to a Class Member, have standing under section 61(1) of the Family Law Act or equivalent legislation.","status":"Claims not yet open","geographic":["Canada-wide (Except Quebec)"],"deadline":"","lastVerifiedAt":"2026-08-16","isSelf":false},{"slug":"national-opioids-mylan-2026","title":"Mylan Settlement","classDefinition":"All persons in Canada (except Quebec) who were prescribed or consumed any opioid Product, together with their heirs, and any member of the Family Law Class. The Family Law Class includes all persons in Canada who, by reason of a relationship to a Class Member, have standing under section 61(1) of Ontario's Family Law Act or equivalent legislation in another province or territory, or the common law.","status":"Claims not yet open","geographic":["Canada-wide (Except Quebec)"],"deadline":"","lastVerifiedAt":"2026-08-16","isSelf":false}]},"cardSummary":"If you took prescription opioids in Canada, or a close family member did, a proposed $28.5 million settlement with Purdue Canada may affect you. Claims have not opened yet.","proofRequired":"","claimTime":"","claimAmount":"","coverageStartDate":"","coverageEndDate":"","deadline":"","optOutDeadline":"2026-05-04","objectionDeadline":null,"approvalHearingDate":"2026-09-16","approvalHearingDates":[{"date":"2026-09-16","label":""}],"approvalPending":false,"seriousHarmEnabled":false,"formHelperEnabled":false,"dateAdded":"2026-08-16","lastUpdated":"2026-08-16","firstPublishedAt":"2026-08-16 16:05:08","claimsOpenedAt":null,"lastVerifiedAt":"2026-08-16","languages":["en","fr"]},{"id":"valeant-opioid-settlement-2026","slug":"valeant-opioid-settlement-2026","title":"Valeant and Bausch Health Settlement","category":"Pharmaceutical and Medical Devices","status":"Claims not yet open","tags":{"industry":["Pharmaceutical and medical devices"],"geographic":["Canada-wide (Except Quebec)"],"recoveryType":["Cash payment"],"documentation":["To be determined"],"eligibilityTrigger":["Was a patient or received treatment"]},"classDefinition":"All persons in Canada (except Quebec) who were prescribed or consumed any opioid product (as defined in the Settlement Agreement), together with their heirs, and any member of the Family Law Class. The Family Law Class includes persons who, by reason of a relationship to a Class Member, have standing under section 61(1) of the Family Law Act or equivalent legislation.","plainLanguageSummary":"If you were prescribed or consumed opioid products in Canada (outside Quebec) since January 1, 1996, or you are a family member of someone who was, you may be eligible for a share of a proposed $600,000 settlement with Valeant if the court approves it.","eligibilityCriteria":[],"recoveryRange":"Share of a $600,000 settlement fund, distribution plan to be approved later","filingInstructions":"","caseBackground":"A national class action claims that major pharmaceutical companies promoted opioid medications for chronic conditions starting in the 1990s, leading to widespread addiction among people who were prescribed them. The lawsuit also says the companies failed to warn about the dangers of these drugs. Valeant Canada and Bausch Health Companies, which sold opioid products in Canada such as M.O.S. (Morphine Hydrochloride) products, Cophylac, Onsolis, Opana ER, Painex, Kadian and Ralivia, have agreed to a proposed settlement of $600,000 to end the claims against them. Valeant denies the allegations, and no court has found it liable.\n\nThe settlement must be approved by the Ontario Superior Court of Justice before it becomes final. A settlement approval hearing is scheduled for September 16, 2026 in Toronto. The lawsuit continues against the other pharmaceutical companies that have not settled, and lawyers for the class plan to ask the court later in 2026 to approve a plan for distributing the settlement money to class members. Details on how to make a claim will be announced after that.","administratorName":"","administratorContacts":[],"administratorRole":"claims","agentName":null,"agentContacts":[],"agentClaimFormHelp":false,"classCounselName":"Koskie Minsky LLP","classCounselContacts":[{"type":"phone","label":"","value":"1-833-630-1776"},{"type":"email","label":"","value":"opioidclassaction@kmlaw.ca"},{"type":"mail","label":"","value":"Koskie Minsky LLP, 20 Queen Street West, Suite 900, Toronto, ON, M5H 3R3"},{"type":"online","label":"","value":"https://kmlaw.ca/cases/liability-for-opioid-epidemic/"}],"classCounselFirms":[{"name":"Koskie Minsky LLP","region":"","contacts":[{"type":"phone","label":"","value":"1-833-630-1776"},{"type":"email","label":"","value":"opioidclassaction@kmlaw.ca"},{"type":"mail","label":"","value":"Koskie Minsky LLP, 20 Queen Street West, Suite 900, Toronto, ON, M5H 3R3"},{"type":"online","label":"","value":"https://kmlaw.ca/cases/liability-for-opioid-epidemic/"}]}],"submissionMethods":[],"sourceDocuments":[{"url":"/uploads/1aa5f348b9bfcdecfcd11d7f-Long_Form_Notice_of_Certification_and_Settlement_Approval_Hearing_Valeant.pdf","title":"Notice to Class Members"},{"url":"/uploads/a873b44bedd53cc993035e52-Long_Form_Notice_of_Certification_and_Settlement_Approval_Hearing_Valeant_FR.pdf","title":"Avis aux membres du groupe"}],"shortFormNoticeUrl":"/uploads/36d8dff92ac0fd1b5748554a-Short_Form_Notice_of_Certification_and_Settlement_Approval_Hearing_Valeant.pdf","longFormNoticeUrl":"/uploads/1aa5f348b9bfcdecfcd11d7f-Long_Form_Notice_of_Certification_and_Settlement_Approval_Hearing_Valeant.pdf","settlementAgreementUrl":"","claimFormDocumentUrl":"","claimForms":[],"claimFormsButtonLabel":"claim-form","claimFormsUnavailable":false,"claimFormsUnavailableReason":null,"claimFormGuides":[],"additionalDocuments":[],"optOutFormUrl":"","optOutInstructions":"To opt out, you must complete an Opt Out Form and email it or mail it (postmarked) to Class Counsel by May 4, 2026, at opioidclassaction@kmlaw.ca or Koskie Minsky LLP, 20 Queen Street West, Suite 900, Toronto, ON, M5H 3R3, Re: Opioids Class Action. You cannot opt out by phone or through the website. That deadline has now passed.","objectionFormUrl":null,"objectionInstructions":null,"faqs":[{"answer":"Valeant Canada and Bausch Health Companies have agreed to pay an all-inclusive $600,000 CAD to end the class action against them. The lawsuit continues against the other pharmaceutical companies that have not settled.","question":"What is the proposed settlement?"},{"answer":"Not yet. The settlement must first be approved by the court at a hearing scheduled for September 16, 2026. Class Counsel then intends to ask the court later in 2026 to approve a plan for distributing the settlement money, and will give notice of how to make a claim.","question":"When will I be able to make a claim?"},{"answer":"If you support the proposed settlement, you do not need to do anything. To receive future notices about the settlement, register by emailing opioidclassaction@kmlaw.ca.","question":"What do I need to do right now?"},{"answer":"No. The deadline to submit an Objection Form or an Opt Out Form to Class Counsel was May 4, 2026, and it has passed.","question":"Can I still object to the settlement or opt out?"},{"answer":"No. Class members are not charged for the services of Class Counsel. Class Counsel will ask the court to approve a fee of 25% of the settlement funds at the approval hearing, and the court will decide whether that is fair.","question":"Will I have to pay legal fees?"}],"eligibilityChecker":{"questions":[{"id":"prescribed-or-consumed-opioids","text":"Were you prescribed or did you consume any opioid product in Canada since January 1, 1996, or are you an heir or family member of someone who was?","type":"yes_no","helpText":"Opioid products include drugs such as morphine, codeine, fentanyl, oxycodone, hydromorphone, methadone and tramadol.","qualifyingAnswer":"yes","criticalForEligibility":true},{"id":"outside-quebec","text":"Do you live in Canada outside of Quebec?","type":"yes_no","helpText":"The settlement class covers people in Canada except Quebec.","qualifyingAnswer":"yes","criticalForEligibility":true}],"uncertainMessage":"Some of your answers were Not sure, so we could not confidently determine your eligibility.","qualifyingMessage":"Based on your answers, you appear to fall within the class definition for this settlement.","nonQualifyingMessage":"Based on your answers, you do not appear to fall within the class definition for this settlement."},"claimCategories":[],"proceedings":null,"relatedSlugs":[],"group":{"slug":"opioid-class-action","title":"Opioid Class Action","summary":"Three proposed settlements with Purdue Canada, Valeant and Mylan in the national opioid class action, Gebien v. Apotex, brought on behalf of Canadians who were prescribed or consumed opioid products and allege opioid dependency or addiction. Each settling defendant denies the allegations and the class action continues against the remaining defendants.","membersIntro":null,"structure":"multi_settlement","members":[{"slug":"purdue-canada-opioids-2026","title":"Purdue Canada Settlement","classDefinition":"All persons in Canada, except Excluded Persons, who were prescribed or consumed any opioid Product, together with their heirs, and any member of the Family Law Class (relatives with standing under s. 61(1) of the Family Law Act or equivalent legislation). Excluded Persons include anyone prescribed only OxyContin or OxyNEO between January 1, 1996 and February 28, 2017 and no other Products, officers or directors of the defendants, and members of the class in the Bourassa Class Action.","status":"Claims not yet open","geographic":["Canada-wide"],"deadline":"","lastVerifiedAt":"2026-08-16","isSelf":false},{"slug":"valeant-opioid-settlement-2026","title":"Valeant and Bausch Health Settlement","classDefinition":"All persons in Canada (except Quebec) who were prescribed or consumed any opioid product (as defined in the Settlement Agreement), together with their heirs, and any member of the Family Law Class. The Family Law Class includes persons who, by reason of a relationship to a Class Member, have standing under section 61(1) of the Family Law Act or equivalent legislation.","status":"Claims not yet open","geographic":["Canada-wide (Except Quebec)"],"deadline":"","lastVerifiedAt":"2026-08-16","isSelf":true},{"slug":"national-opioids-mylan-2026","title":"Mylan Settlement","classDefinition":"All persons in Canada (except Quebec) who were prescribed or consumed any opioid Product, together with their heirs, and any member of the Family Law Class. The Family Law Class includes all persons in Canada who, by reason of a relationship to a Class Member, have standing under section 61(1) of Ontario's Family Law Act or equivalent legislation in another province or territory, or the common law.","status":"Claims not yet open","geographic":["Canada-wide (Except Quebec)"],"deadline":"","lastVerifiedAt":"2026-08-16","isSelf":false}]},"cardSummary":"If you or a family member took opioid medications in Canada (outside Quebec) since 1996, a proposed $600,000 settlement with Valeant may affect you. Claims have not opened yet.","proofRequired":"","claimTime":"","claimAmount":"","coverageStartDate":"1996-01-01","coverageEndDate":"","deadline":"","optOutDeadline":"2026-05-04","objectionDeadline":null,"approvalHearingDate":"2026-09-16","approvalHearingDates":[{"date":"2026-09-16","label":""}],"approvalPending":false,"seriousHarmEnabled":false,"formHelperEnabled":false,"dateAdded":"2026-08-16","lastUpdated":"2026-08-16","firstPublishedAt":"2026-08-16 04:58:57","claimsOpenedAt":null,"lastVerifiedAt":"2026-08-16","languages":["en","fr"]},{"id":"national-opioids-mylan-2026","slug":"national-opioids-mylan-2026","title":"Mylan Settlement","category":"Pharmaceutical and Medical Devices","status":"Claims not yet open","tags":{"industry":["Pharmaceutical and medical devices"],"geographic":["Canada-wide (Except Quebec)"],"recoveryType":["Cash payment"],"documentation":["To be determined"],"eligibilityTrigger":["Was a patient or received treatment"]},"classDefinition":"All persons in Canada (except Quebec) who were prescribed or consumed any opioid Product, together with their heirs, and any member of the Family Law Class. The Family Law Class includes all persons in Canada who, by reason of a relationship to a Class Member, have standing under section 61(1) of Ontario's Family Law Act or equivalent legislation in another province or territory, or the common law.","plainLanguageSummary":"If you were prescribed or consumed prescription opioids in Canada (outside Quebec), or you are a close family member or heir of someone who was, you may be affected by a proposed $200,000 settlement with Mylan Pharmaceuticals that is awaiting court approval.","eligibilityCriteria":[],"recoveryRange":"Share of a $200,000 settlement fund; individual amounts not yet determined","filingInstructions":"","caseBackground":"A national class action claims that several pharmaceutical companies promoted prescription opioids for chronic conditions starting in the 1990s, leading to widespread addiction, and failed to warn about the dangers of taking opioids. The lawsuit was brought on behalf of Canadians who were prescribed or consumed opioids, along with their family members and heirs.\n\nOne of the companies, Mylan Pharmaceuticals ULC, has agreed to a proposed settlement of $200,000 to end the claims against it, while denying the allegations. The lawsuit continues against the other pharmaceutical companies. The Ontario Superior Court of Justice will decide whether to approve the settlement at a hearing on September 16, 2026. A plan for distributing money to class members is expected to be proposed later in 2026, and no claims can be made yet.","administratorName":"","administratorContacts":[],"administratorRole":"claims","agentName":null,"agentContacts":[],"agentClaimFormHelp":false,"classCounselName":"Koskie Minsky LLP","classCounselContacts":[{"type":"phone","label":"","value":"1-833-630-1776"},{"type":"email","label":"","value":"opioidclassaction@kmlaw.ca"},{"type":"mail","label":"","value":"Koskie Minsky LLP, 20 Queen Street West, Suite 900, Toronto, ON, M5H 3R3"},{"type":"online","label":"","value":"https://kmlaw.ca/cases/liability-for-opioid-epidemic/"}],"classCounselFirms":[{"name":"Koskie Minsky LLP","region":"","contacts":[{"type":"phone","label":"","value":"1-833-630-1776"},{"type":"email","label":"","value":"opioidclassaction@kmlaw.ca"},{"type":"mail","label":"","value":"Koskie Minsky LLP, 20 Queen Street West, Suite 900, Toronto, ON, M5H 3R3"},{"type":"online","label":"","value":"https://kmlaw.ca/cases/liability-for-opioid-epidemic/"}]}],"submissionMethods":[],"sourceDocuments":[{"url":"/uploads/5c43796abd8204bf23e856be-Long_Form_Notice_of_Certification_and_Settlement_Approval_Hearing_Mylan.pdf","title":"Notice to Class Members"},{"url":"/uploads/d3230841d7700d2376ae588e-Long_Form_Notice_of_Certification_and_-Settlement_Approval_Hearing_Mylan_FR.pdf","title":"Avis aux membres du groupe"}],"shortFormNoticeUrl":"/uploads/7b16ad036cbf6b7438ccef7c-Short_Form_Notice_of_Certification_and_Settlement_Approval_Hearing_Mylan.pdf","longFormNoticeUrl":"/uploads/5c43796abd8204bf23e856be-Long_Form_Notice_of_Certification_and_Settlement_Approval_Hearing_Mylan.pdf","settlementAgreementUrl":"","claimFormDocumentUrl":"","claimForms":[],"claimFormsButtonLabel":"claim-form","claimFormsUnavailable":false,"claimFormsUnavailableReason":null,"claimFormGuides":[],"additionalDocuments":[],"optOutFormUrl":"","optOutInstructions":"To opt out, you must send a written Opt Out Request to Class Counsel by mail to Koskie Minsky LLP, 20 Queen Street West, Suite 900, Toronto, ON, M5H 3R3, RE: Opioid Class Action. The request must include the case name and court file number (CV-19-00620048-00CP), your full name and address, a declaration that you want to be excluded, whether you consumed a Mylan product, and your signature. The deadline to opt out was May 4, 2026, and it has passed.","objectionFormUrl":null,"objectionInstructions":null,"faqs":[{"answer":"Mylan has agreed to pay $200,000 to settle the claims against it. This amount will be held in an interest-bearing account for the benefit of the class while the lawsuit continues against the other pharmaceutical companies.","question":"How much money is in the settlement?"},{"answer":"Not yet. The settlement must first be approved by the court at a hearing on September 16, 2026. Class Counsel expects to ask the court to approve a plan for distributing the settlement money later in 2026, and will provide notice of how to make a claim at that time.","question":"Can I make a claim for compensation now?"},{"answer":"No. The deadline to object was May 4, 2026, and it has passed. Objections had to be submitted to Class Counsel using an Objection Form.","question":"Can I object to the proposed settlement?"},{"answer":"No. The deadline to opt out was May 4, 2026, and it has passed. Class members who did not opt out remain in the class action and will be bound by the settlement if the court approves it.","question":"Can I opt out of the settlement?"},{"answer":"If you support the proposed settlement, you do not need to do anything. To receive future notices about the settlement, you can register by emailing opioidclassaction@kmlaw.ca. Updates will also be posted at https://kmlaw.ca/cases/liability-for-opioid-epidemic/.","question":"What do I need to do right now?"}],"eligibilityChecker":{"questions":[{"id":"prescribed-or-consumed-opioids","text":"Were you prescribed or did you consume any prescription opioid product?","type":"yes_no","helpText":"If you were not, you may still qualify as a family member or heir of someone who was.","qualifyingAnswer":"yes","criticalForEligibility":true},{"id":"in-canada-outside-quebec","text":"Are you a person in Canada outside of Quebec?","type":"yes_no","qualifyingAnswer":"yes","criticalForEligibility":true},{"id":"family-member-or-heir","text":"If you did not take opioids yourself, are you an heir or a close family member of someone who was prescribed or consumed opioids?","type":"yes_no","helpText":"Family members with standing under family law legislation, such as spouses, children, and parents, may be included.","qualifyingAnswer":"yes","criticalForEligibility":false}],"uncertainMessage":"Some of your answers were Not sure, so we could not confidently determine your eligibility.","qualifyingMessage":"Based on your answers, you appear to fall within the class definition for this settlement.","nonQualifyingMessage":"Based on your answers, you do not appear to fall within the class definition for this settlement."},"claimCategories":[],"proceedings":null,"relatedSlugs":[],"group":{"slug":"opioid-class-action","title":"Opioid Class Action","summary":"Three proposed settlements with Purdue Canada, Valeant and Mylan in the national opioid class action, Gebien v. Apotex, brought on behalf of Canadians who were prescribed or consumed opioid products and allege opioid dependency or addiction. Each settling defendant denies the allegations and the class action continues against the remaining defendants.","membersIntro":null,"structure":"multi_settlement","members":[{"slug":"purdue-canada-opioids-2026","title":"Purdue Canada Settlement","classDefinition":"All persons in Canada, except Excluded Persons, who were prescribed or consumed any opioid Product, together with their heirs, and any member of the Family Law Class (relatives with standing under s. 61(1) of the Family Law Act or equivalent legislation). Excluded Persons include anyone prescribed only OxyContin or OxyNEO between January 1, 1996 and February 28, 2017 and no other Products, officers or directors of the defendants, and members of the class in the Bourassa Class Action.","status":"Claims not yet open","geographic":["Canada-wide"],"deadline":"","lastVerifiedAt":"2026-08-16","isSelf":false},{"slug":"valeant-opioid-settlement-2026","title":"Valeant and Bausch Health Settlement","classDefinition":"All persons in Canada (except Quebec) who were prescribed or consumed any opioid product (as defined in the Settlement Agreement), together with their heirs, and any member of the Family Law Class. The Family Law Class includes persons who, by reason of a relationship to a Class Member, have standing under section 61(1) of the Family Law Act or equivalent legislation.","status":"Claims not yet open","geographic":["Canada-wide (Except Quebec)"],"deadline":"","lastVerifiedAt":"2026-08-16","isSelf":false},{"slug":"national-opioids-mylan-2026","title":"Mylan Settlement","classDefinition":"All persons in Canada (except Quebec) who were prescribed or consumed any opioid Product, together with their heirs, and any member of the Family Law Class. The Family Law Class includes all persons in Canada who, by reason of a relationship to a Class Member, have standing under section 61(1) of Ontario's Family Law Act or equivalent legislation in another province or territory, or the common law.","status":"Claims not yet open","geographic":["Canada-wide (Except Quebec)"],"deadline":"","lastVerifiedAt":"2026-08-16","isSelf":true}]},"cardSummary":"For people in Canada (outside Quebec) who were prescribed or took prescription opioids, and their close family members. A proposed $200,000 settlement with Mylan Pharmaceuticals awaits court approval.","proofRequired":"","claimTime":"","claimAmount":"","coverageStartDate":"","coverageEndDate":"","deadline":"","optOutDeadline":"2026-05-04","objectionDeadline":null,"approvalHearingDate":"2026-09-16","approvalHearingDates":[{"date":"2026-09-16","label":""}],"approvalPending":false,"seriousHarmEnabled":false,"formHelperEnabled":false,"dateAdded":"2026-08-16","lastUpdated":"2026-08-16","firstPublishedAt":"2026-08-16 16:13:38","claimsOpenedAt":null,"lastVerifiedAt":"2026-08-16","languages":["en","fr"]}]}